Pharmaceuticals
SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe
FRANKFURT, Germany, Nov. 8, 2019 /PRNewswire/ -- From November 5 to 7, 2019, CPhI Worldwide Europe was held in the Exhibition CentreFrankfurt, Germany. Dong Jianhua, executive director of Sinochem Pharmaceutical Co., Ltd., led a delegation to attend the exhibition. Sinochem Pharmaceutical has be...
2019-11-08 17:36
2670
Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes
BAD HOMBURG, Germany, Nov. 8, 2019 /PRNewswire/ -- A new systematic literature review and meta-analysis[1] confirms and extends previous results that omega-3 (ω-3) fatty-acid enriched parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients. Including a tot...
2019-11-08 11:00
2575
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost
PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...
2019-11-07 21:02
1620
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million
HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...
2019-11-07 19:04
6936
Bactiguard Holding AB (publ): Interim Report for Q3 2019
STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...
2019-11-07 15:23
6505
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma
SUZHOU, China, Nov. 7, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday...
2019-11-07 11:02
2459
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.
- Bioeq agreement brings promise of their leading Lucentis® biosimilar for the treatment of retinopathies one step nearer for U.S. patients - ZÜRICH, Nov. 7, 2019 /PRNewswire/ -- Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coherus BioSciences, In...
2019-11-07 05:14
2225
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364. Antengene Co...
2019-11-07 01:40
2538
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019
SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company inChina focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "t...
2019-11-07 01:00
2564
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports
PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...
2019-11-06 18:01
1666
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation
HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation...
2019-11-06 17:21
1248
15 Years of P-MEC China Driving Global Pharma Technology Forward in China
SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- P-MEC China
2019-11-06 14:00
605
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)
80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months PLYMOUTH MEETING, Pennsylvania, Nov. 5, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today positive interim results from Inovio's Phase 2 study (NCT03491683) of newl...
2019-11-05 21:00
2578
Health Charities Benefit from Nationwide Fundraising Campaign
SYDNEY, Nov. 5, 2019 /PRNewswire/ -- AFT Pharmaceuticals is getting behind three charities in a bid to help them raise vital funding for vulnerable Aussies - and get people talking about health. The company's founder and CEO, Hartley Atkinson says the initiative is an opportunity to give back to...
2019-11-05 05:30
972
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
- Alliance to focus combined expertise and investment to maximise Jardiance® for people with type 2 diabetes, heart failure, and chronic kidney disease - Alliance to continue to include three product families – empagliflozin, linagliptin and insulin glargine INGELHEIM, Germany, and INDIANAPOLIS,...
2019-11-04 22:00
4018
Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds
* The survey aims to better understand the lives of women living with advanced breast cancer and seeks to provide support to these women around the globe.[1] * With new and better treatments, patients with advanced breast cancer are now living longer and better than before SINGAPORE, Nov. 4, ...
2019-11-04 08:15
1325
Encore Medical Education Will Publish the Official Best of SABCS(R) News From the 2019 San Antonio Breast Cancer Symposium (SABCS(R)) Starting December 12, 2019
SAN ANTONIO, Texas, Nov. 1, 2019 /PRNewswire/ -- Encore Medical Education (
www.encoremeded.com
2019-11-01 23:00
3606
High Performance Swine Production With Reduced Use of Antibiotics: Second Workshop by EW Nutrition and OPP Group
From 4 to 7 November, in Lleida, Spain, OPP Group and EW Nutrition are hosting their second workshop on animal health and welfare with reduced antibiotic use LLEIDA, Spain, Nov. 1, 2019 /PRNewswire/ -- The two-day event offers swine producers and other stakeholders essential, actionable informati...
2019-11-01 20:22
2158
Dachser Air & Sea Logistics certified for pharmaceutical shipments on three continents
KEMPTEN, Germany, Nov. 1, 2019 /PRNewswire/ -- Following Frankfurt, Mumbai, and
Hyderabad, Atlanta is now Dachser's fourth location to receive certification in
ten months, further expanding the company's network services for its customers
in the life science and healthcare sector.
2019-11-01 09:00
2994
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA
GERMANTOWN, Maryland, Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will begin trading on the Nasdaq Capital Market under the ticker symbol, NASDAQ: SNCA beginning onN...
2019-10-31 23:00
5463
Week's Top Stories
Most Reposted
ROSHI Unveils Comprehensive Report on the Future of Digital Lending, Highlighting Global Trends for 2025 and Beyond
[Picked up by 317 media titles]
2024-10-02 10:03
Matterport Fall 2024 Release: Insights Meets Imagination elevates the platform with generative AI and more
[Picked up by 305 media titles]
2024-10-02 09:00
From Boomers to Zoomers: how retailers and eCommerce firms can boost sales and loyalty
[Picked up by 305 media titles]
2024-09-30 13:00
MOAJ Holding invests $30M in Joint Venture with MediSun Energy to Tackle Water Scarcity and Brine Challenges in Saudi Arabia
[Picked up by 293 media titles]
2024-09-30 09:00
Graid Technology and INFINITIX Turn Your SuperPOD into a Real Business Opportunity at Tech Week Singapore
[Picked up by 293 media titles]
2024-10-04 11:00
Most Read
Matterport Fall 2024 Release: Insights Meets Imagination elevates the platform with generative AI and more
2024-10-02 09:00
9750
ROSHI Unveils Comprehensive Report on the Future of Digital Lending, Highlighting Global Trends for 2025 and Beyond
2024-10-02 10:03
9134
From Boomers to Zoomers: how retailers and eCommerce firms can boost sales and loyalty
2024-09-30 13:00
6954